Concepedia

Delvyn C. Case

DC

24

Publications

1.7K

Citations

18

H-Index

1976

Active since

Affiliations

Maine Medical Center(Current)

Maine Medical Center

University of Arizona

University of California, San Francisco

State University of New York

Delvyn C. Case is an author at Maine Medical Center specializing in medicine, oncology, and pharmacotherapy.

Top concepts

Publications per year

1976–2007

24

Publications

24

Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD).

Arthur T. Skarin, G P Canellos, David S. H. Rosenthal et al. · Journal of Clinical Oncology · 1983 · 340 citations

, , +14

Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol

Delvyn C. Case, Burton J. Lee, Bayard D. Clarkson · The American Journal of Medicine · 1977 · 220 citations

, , +8

Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination Chemotherapy

Delvyn C. Case, R. M. Bukowski, Robert W. Carey et al. · JNCI Journal of the National Cancer Institute · 1993 · 201 citations

Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.

Z Arlin, Delvyn C. Case, J. Moore et al. · PubMed · 1990 · 199 citations

A Long-Term Study of Prognosis on Monoclonal Gammopathy of Undetermined Significance.

Delvyn C. Case, Marjorie A. Boyd · Blood · 2006 · 91 citations

Rows per page

1–5 of 24